Showing 22 of 22 results

Organisation Mondiale de la Santé (OMS)
Le présent document remplace la précédente note de synthèse sur les vaccins anti-hépatite A, publiée par l’OMS en 2012. Il contient des recommandations sur l’utilisation hors indications de...
World Health Organization (WHO)
This document replaces the 2012 WHO position paper on hepatitis A vaccines. It contains off-label recommendations.
Xin Yue et al.
Background: Infection with hepatitis A and hepatitis B virus can increase the risk of morbidity and mortality in persons with chronic liver disease (CLD). The Advisory Committee on Immunization...
Carlos K.H. Wong et al.
Objectives: To describe and systematically review the modelling and reporting of cost-effectiveness analysis of vaccination in Hong Kong, and to identify areas for quality enhancement in future...
Gallone MF et al.
Hepatitis A is a common infectious disease worldwide that was endemic in many regions of Southern Italy, such as Apulia region. After a large hepatitis A outbreak occurred between 1996 and 1997, in...
Sam F. Halabi et al.
Vaccines are extremely safe and harm is rare. Worldwide, more than 30 000 vaccine doses are delivered per second through routine immunization programs, which, in turn, prevent an estimated 2...
Craig Thompson et al.
In November 2005, hepatitis A vaccine was funded under the Australian National Immunisation Program for Aboriginal and Torres Strait Islander (Indigenous) children aged 12–24 months in the targeted...
Jorge E González, Analía Urueña, Analía Rearte, María E Pérez Carrega, Rogelio Calli, María F Pagani, Andrea Uboldi, Rosalía Vicentín, Angela Gentile, Margarita Ramonet, Carla Vizzotti, Patricia Caglio, María C Cañero-Velasco
Background: Single-dose Hepatitis A Virus (HAV) vaccination was implemented in all Argentinean children aged 12 months in 2005. Previous studies demonstrated high prevalence of protective antibody...
Serhat Unal, Abdullah Sayiner, Devrim E. Alici
Immunization is an important component of preventive healthcare services aiming to prevent and eventually eradicate infectious diseases by immunizing people before they become infected. Although...
Sina Ogholikhan & Kathleen B. Schwarz
Viral hepatitis is a serious health problem all over the world. However, the reduction of the morbidity and mortality due to vaccinations against hepatitis A and hepatitis B has been a major...
Jeffrey D Stanaway et al.
Summary Background With recent improvements in vaccines and treatments against viral hepatitis, an improved understanding of the burden of viral hepatitis is needed to inform global intervention...
Ott J et al.
OBJECTIVE: Data on duration and long-term protective effects of hepatitis A vaccines (HepA) have not been reviewed using a systematic approach. Our objective is to provide a comprehensive review of...
Axel Bonačić Marinović, Corien Swaan, Jim van Steenbergen, Mirjam Kretzschmar
The extent to which reporting delays should be reduced to gain substantial improvement in outbreak control is unclear. We developed a model to quantitatively assess reporting timeliness. Using...
Centers for Disease Control and Prevention (CDC)
As part of the Centers for Disease Control and Prevention’s (CDC) National Notifiable Diseases Surveillance System (NNDSS) (1), viral hepatitis case-reports are received electronically from U.S....
Heidi J Larson et al
The Viral Hepatitis Prevention Board met in London, UK (June 5–6, 2015), to discuss options towards a future free of viral hepatitis. Hepatitis B vaccine was introduced in 1982 and is now included...
Lavanchy D.
In countries where hepatitis A is highly endemic, exposure to hepatitis A virus (HAV) is almost universal before the age of 10years, and large-scale immunization efforts are not required. In...
Rinderknecht S et al.
Hepatitis A vaccination in early childhood has reduced hepatitis A transmission. Coadministration of hepatitis A vaccine with other childhood vaccines may assist completion of the age-appropriate...
Sachiko Ozawa et al.
Triangulation of results from two methods captured a richer story behind vaccine adoption decisions for hepatitis A. The discrepancy between policymakers’ beliefs and existing data suggest a...
Espul C et al.
The study was conducted to further investigate the single-dose approach of hepatitis A vaccination, while providing supportive data on the flexibility of booster administration. Participants received...
Choe YJ et al.
This study was performed to determine the priority of vaccine introduction for five vaccine-preventable diseases (VPDs) caused by Haemophilus influenzae type b (Hib), pneumococcus (Spn), hepatitis A...
Terri B. Hyde et al.
We conducted a systematic review of the published literature to examine the impact of new vaccine introduction on countries’ immunization and broader health systems. Six publication databases were...
Melissa G Collier et al.
Imported frozen pomegranate arils were identified as the vehicle early in the investigation by combining epidemiology—with data from several sources—genetic analysis of patient samples, and...